Investor AB's Laborie to buy Cogentix Medical for $239 mln
Laborie Medical Technologies Inc has agreed to buy Cogentix Medical Inc (Nasdaq: CGNT), a Minnetonka, Minnesota-based urology-focused medical device company, for about US$239 million. The acquisition, expected to close in Q2 2018, will see Cogentix become a subsidiary of Laborie, a Toronto-based maker of medical diagnostics and devices for the pelvic health and gastroenterology market. Accelmed Growth Partners and Lewis Pell, which together own a 60 percent interest in Cogentix, have agreed to support the deal. Laborie was in 2016 acquired by Patricia Industries, an investment arm of Sweden's Investor AB, from Audax Private Equity.
12 March 2018•4 mins read
